Case-control study compares metabolic and laboratory biomarkers in early-onset versus late-onset colorectal cancer

Researchers used a large US database to compare metabolic, inflammatory, and laboratory abnormalities between patients diagnosed at ages 18-49 versus 50-75. (Cancers)